Deutsche Bank’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $47.4M | Buy |
631,663
+272,781
| +76% | +$17.5M | 0.01% | 665 |
|
|
2026
Q1 | $20.2M | Sell |
358,882
-42,876
| -11% | -$2.79M | 0.01% | 846 |
|
|
2025
Q4 | $32.2M | Buy |
401,758
+112,238
| +39% | +$7.54M | 0.01% | 759 |
|
|
2025
Q3 | $14.1M | Sell |
289,520
-170,113
| -37% | -$10.5M | ﹤0.01% | 941 |
|
|
2025
Q2 | $34.3M | Buy |
459,633
+60,218
| +15% | +$3.99M | 0.01% | 681 |
|
|
2025
Q1 | $25.4M | Sell |
399,415
-66,170
| -14% | -$4.5M | 0.01% | 769 |
|
|
2024
Q4 | $36.4M | Buy |
465,585
+13,484
| +3% | +$1.08M | 0.01% | 713 |
|
|
2024
Q3 | $36.3M | Sell |
452,101
-97,667
| -18% | -$7.89M | 0.01% | 687 |
|
|
2024
Q2 | $45.5M | Buy |
549,768
+417,843
| +317% | +$36.8M | 0.02% | 585 |
|
|
2024
Q1 | $11.3M | Sell |
131,925
-72,247
| -35% | -$5.67M | 0.01% | 983 |
|
|
2023
Q4 | $17.5M | Buy |
204,172
+1,297
| +0.6% | +$112K | 0.01% | 830 |
|
|
2023
Q3 | $18.2M | Sell |
202,875
-3,081
| -1% | -$275K | 0.01% | 729 |
|
|
2023
Q2 | $17.5M | Sell |
205,956
-89,838
| -30% | -$7.6M | 0.01% | 823 |
|
|
2023
Q1 | $24.5M | Buy |
295,794
+1,503
| +0.5% | +$122K | 0.01% | 706 |
|
|
2022
Q4 | $23.1M | Buy |
294,291
+4,628
| +2% | +$372K | 0.01% | 724 |
|
|
2022
Q3 | $21.4M | Buy |
289,663
+19,647
| +7% | +$1.41M | 0.01% | 740 |
|
|
2022
Q2 | $17.6M | Buy |
270,016
+5,910
| +2% | +$350K | 0.01% | 812 |
|
|
2022
Q1 | $16.7M | Buy |
264,106
+17,467
| +7% | +$950K | 0.01% | 900 |
|
|
2021
Q4 | $13.1M | Sell |
246,639
-149,964
| -38% | -$9.14M | 0.01% | 1007 |
|
|
2021
Q3 | $28M | Sell |
396,603
-52,206
| -12% | -$3.29M | 0.01% | 778 |
|
|
2021
Q2 | $29.9M | Buy |
448,809
+216,918
| +94% | +$15.3M | 0.01% | 780 |
|
|
2021
Q1 | $25.7M | Buy |
231,891
+208,825
| +905% | +$25.8M | 0.01% | 811 |
|
|
2020
Q4 | $2.74M | Sell |
23,066
-121
| -0.5% | -$13K | ﹤0.01% | 1709 |
|
|
2020
Q3 | $2.02M | Buy |
23,187
+368
| +2% | +$32.2K | ﹤0.01% | 1736 |
|
|
2020
Q2 | $2.04M | Sell |
22,819
-11,594
| -34% | -$1.17M | ﹤0.01% | 1778 |
|
|
2020
Q1 | $3.43M | Sell |
34,413
-67,979
| -66% | -$7.37M | ﹤0.01% | 1444 |
|
|
2019
Q4 | $11.8M | Buy |
102,392
+21,387
| +26% | +$2.59M | 0.01% | 1011 |
|
|
2019
Q3 | $10.2M | Sell |
81,005
-185,488
| -70% | -$23.5M | 0.01% | 1063 |
|
|
2019
Q2 | $32.1M | Sell |
266,493
-308,205
| -54% | -$30.3M | 0.02% | 758 |
|
|
2019
Q1 | $50.3M | Sell |
574,698
-56,581
| -9% | -$5.15M | 0.03% | 582 |
|
|
2018
Q4 | $63.2M | Sell |
631,279
-658,052
| -51% | -$69.1M | 0.04% | 431 |
|
|
2018
Q3 | $148M | Buy |
1,289,331
+461,840
| +56% | +$47.8M | 0.07% | 279 |
|
|
2018
Q2 | $74.2M | Buy |
827,491
+21,565
| +3% | +$1.82M | 0.04% | 504 |
|
|
2018
Q1 | $59M | Buy |
805,926
+505,301
| +168% | +$34.7M | 0.03% | 576 |
|
|
2017
Q4 | $17.5M | Buy |
300,625
+51,538
| +21% | +$2.71M | 0.01% | 1099 |
|
|
2017
Q3 | $11.2M | Sell |
249,087
-19,387
| -7% | -$805K | 0.01% | 1383 |
|
|
2017
Q2 | $10.6M | Buy |
268,474
+227,048
| +548% | +$9.33M | 0.01% | 1365 |
|
|
2017
Q1 | $1.68M | Sell |
41,426
-18,555
| -31% | -$725K | ﹤0.01% | 2360 |
|
|
2016
Q4 | $2.41M | Sell |
59,981
-155,325
| -72% | -$5.86M | ﹤0.01% | 2144 |
|
|
2016
Q3 | $7.79M | Sell |
215,306
-57,369
| -21% | -$1.97M | 0.01% | 1470 |
|
|
2016
Q2 | $7.9M | Buy |
272,675
+181,270
| +198% | +$5.48M | 0.01% | 1451 |
|
|
2016
Q1 | $3.2M | Sell |
91,405
-48,410
| -35% | -$1.56M | ﹤0.01% | 2056 |
|
|
2015
Q4 | $4.51M | Sell |
139,815
-123,030
| -47% | -$3.99M | ﹤0.01% | 1863 |
|
|
2015
Q3 | $8.49M | Buy |
262,845
+162,873
| +163% | +$6.13M | 0.01% | 1402 |
|
|
2015
Q2 | $4.13M | Buy |
99,972
+8,662
| +9% | +$365K | ﹤0.01% | 1927 |
|
|
2015
Q1 | $4.1M | Sell |
91,310
-11,915
| -12% | -$498K | ﹤0.01% | 1928 |
|
|
2014
Q4 | $3.86M | Buy |
103,225
+31,843
| +45% | +$1.17M | ﹤0.01% | 2164 |
|
|
2014
Q3 | $2.49M | Sell |
71,382
-41,628
| -37% | -$1.49M | ﹤0.01% | 2361 |
|
|
2014
Q2 | $3.99M | Sell |
113,010
-67,532
| -37% | -$2.26M | ﹤0.01% | 1984 |
|
|
2014
Q1 | $5.88M | Buy |
180,542
+152,633
| +547% | +$5.83M | ﹤0.01% | 1693 |
|
|
2013
Q4 | $1.18M | Sell |
27,909
-146,686
| -84% | -$6.04M | ﹤0.01% | 2565 |
|
|
2013
Q3 | $6.96M | Buy |
174,595
+24,809
| +17% | +$1.04M | 0.01% | 1589 |
|
|
2013
Q2 | $6.19M | Buy |
+149,786
| New | +$6.06M | 0.01% | 1501 |
|
Other funds holding HAE
AI
Deutsche Bank's HAE Position: Q2 2026 in Review
Deutsche Bank increased its Haemonetics (HAE) stake by 76% in Q2 2026, buying an estimated $17.5M and bringing the position to 631,663 shares worth $47.4M. The position accounts for 0.01% of the portfolio, ranked #665.
Deutsche Bank first reported a position in HAE in Q2 2013 and has held it in 53 quarters since. The position peaked at $148M in Q3 2018. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Deutsche Bank held 631,663 shares of Haemonetics worth $47.4M as of Q2 2026.
- Deutsche Bank bought 272,781 Haemonetics shares in Q2 2026, an estimated $17.5M.
- Haemonetics made up 0.01% of Deutsche Bank's portfolio in Q2 2026, its #665 holding.
- Deutsche Bank first reported a position in Haemonetics in Q2 2013 and has held it in 53 quarters since.
- Deutsche Bank's Haemonetics position peaked at $148M in Q3 2018.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.